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The regulation of luminal ion concentrations is critical for the function of, and transport
between intracellular organelles. The importance of the acidic pH in the compartments
of the endosomal-lysosomal pathway has been well-known for decades. Besides the
V-ATPase, which pumps protons into their lumen, a variety of ion transporters and
channels is involved in the regulation of the organelles’ complex ion homeostasis.
Amongst these are the intracellular members of the CLC family, ClC-3 through ClC-7.
They localize to distinct but overlapping compartments of the endosomal-lysosomal
pathway, partially with tissue-specific expression. Functioning as 2Cl−/H+ exchangers,
they can support the vesicular acidification and accumulate luminal Cl−. Mutations
in the encoding genes in patients and mouse models underlie severe phenotypes
including kidney stones with CLCN5 and osteopetrosis or hypopigmentation with
CLCN7. Dysfunction of those intracellular CLCs that are expressed in neurons lead to
neuronal defects. Loss of endosomal ClC-3, which heteromerizes with ClC-4, results
in neurodegeneration. Mutations in ClC-4 are associated with epileptic encephalopathy
and intellectual disability. Mice lacking the late endosomal ClC-6 develop a lysosomal
storage disease with reduced pain sensitivity. Human gene variants have been associated
with epilepsy, and a gain-of-function mutation causes early-onset neurodegeneration.
Dysfunction of the lysosomal ClC-7 leads to a lysosomal storage disease and
neurodegeneration in mice and humans. Reduced luminal chloride, as well as altered
calcium regulation, has been associated with lysosomal storage diseases in general. This
review discusses the properties of endosomal and lysosomal Cl−/H+ exchange by CLCs
and how various alterations of ion transport by CLCs impact organellar ion homeostasis
and function in neurodegenerative disorders.
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INTRODUCTION
A plethora of ion channels and transporters are responsible for the establishment and maintenance
of particular ion concentrations within cells and their membrane-bounded organelles. This ion
homeostasis is essential for cellular physiology and its perturbation may lead to dysfunction and
eventually to cell death. As long-living post-mitotic cells, neurons are particularly reliant on a
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functioning endosomal-lysosomal system because of its
function in cellular clearance and stress sensing (Boland et al.,
2018; Mallucci et al., 2020; Nixon, 2020). Numerous pumps,
transporters and channels also mediate the transport of ions
required for the physiological functions of these compartments
in the endosomal-lysosomal pathway and their dysfunction
often underlies inherited disorders of various kinds (Xu and
Ren, 2015; Xu et al., 2015; Astaburuaga et al., 2019; Huizing and
Gahl, 2020). A key player in the ion homeostasis of endosomes
and lysosomes, as well as synaptic vesicles, is the V-ATPase. This
multi-subunit enzyme pumps protons into the vesicular lumen
and generates the acidic internal pH that regulates enzyme
activities, secondary active transport, and membrane trafficking
(Mellman et al., 1986; Marshansky and Futai, 2008; Mindell,
2012). Besides the pH, calcium ions (Ca2+) have been shown
to be of pivotal importance to fusion and fission processes and
signaling from endosomes and lysosomes (Luzio et al., 2007;
Morgan et al., 2011; Lakpa et al., 2020). For the other major
inorganic ions, sodium (Na+), potassium (K+) and chloride
(Cl−) it has become clearer during the last years that they may
play roles beyond merely provide for electrical and osmotic
balance of the organelles. Data from patients, mouse models and
cell biophysical measurements highlight an important role for
Cl− which is accumulated in a secondary active transport by CLC
Cl−/H+ exchangers (Jentsch, 2007; Stauber and Jentsch, 2013;
Schwappach, 2020). Loss, dysfunction or mutations altering
biophysical properties of these CLCs lead to severe phenotypes,
including neurological defects and neurodegeneration for those
CLCs expressed in neurons (Stauber et al., 2012; Jentsch and
Pusch, 2018).
In this review we will discuss the physiological roles of
the CLC Cl−/H+ exchangers in the endosomal-lysosomal
pathway and their involvement in neuropathologies
including neurodegeneration.
THE CLC FAMILY OF CL– CHANNELS AND
CL–/H+ EXCHANGERS
The most abundant physiological anion is chloride. Like for
other ions, there are various chloride channels and transporters
that conduct chloride, either alone or in symport with, or
exchange for other ions. Among these are the members
of the CLC family, which notably comprises both chloride
channels and chloride/proton exchangers (Stauber et al., 2012;
Jentsch and Pusch, 2018). In mammals, there are nine CLC
family members that can be divided in three groups by their
sequence homology. The first branch contains ClC-1, ClC-
2, ClC-Ka, and ClC-Kb, all chloride channels localized to
the plasma membrane. By contrast, ClC-3, ClC-4, and ClC-
5 of the second group and lastly ClC-6 and ClC-7 function
as chloride/proton exchangers on intracellular compartments,
mainly in the endosomal/lysosomal pathway.
CLCs function as dimers–mostly homomeric, but some CLCs
can heteromerize within the same homology branch–with two
independent translocation pathways (Jentsch and Pusch, 2018).
Each subunit is composed of a transmembrane domain with
a complex structure of multiple alpha helices spanning or
penetrating the membrane (Dutzler et al., 2002), and a globular
cytosolic domain containing two cystathionine-β-synthase (CBS)
domains (Figure 1). The CBS domains of some CLCs can bind
adenine nucleotides and may be involved in the regulation and
common gating of the transporter or channel (Meyer et al.,
2007; Ludwig et al., 2013; Jentsch and Pusch, 2018; Grieschat
et al., 2020; Schrecker et al., 2020). Some CLCs additionally
bind accessory proteins. Barttin serves as a β-subunit for ClC-Ka
and –kb (Estévez et al., 2001) and more recently, an interaction
with ClC-5 has been reported (Wojciechowski et al., 2018). ClC-
2 and ClC-7 bind to GlialCAM and Ostm1, respectively, that
contribute to the subcellular localization, protein stability or ion
transport activity of the CLCs (Lange et al., 2006; Leisle et al.,
2011; Jeworutzki et al., 2012). A conserved glutamate residue
in the ion translocation pathway is critically involved in the
gating of the plasmamembrane CLC channels and hence referred
to as a “gating glutamate” (Jentsch and Pusch, 2018). In the
intracellular CLC exchangers, this glutamate is crucial for the
strong outward rectification and for the coupling of Cl− transport
to H+ countertransport. CLC exchangers typically (there are
some exceptions in other species) possess a further glutamate,
referred to as “proton glutamate,” whose mutation abolishes or
strongly diminishes the transport of both protons and chloride
(Jentsch and Pusch, 2018; Pusch and Zifarelli, 2021).
Among the CLC channels of the plasma membrane, ClC-1 is
expressed in skeletal muscle where it mediates the major resting
conductance and hence is involved in the control of muscular
excitability (Steinmeyer et al., 1991; Stauber et al., 2012; Jentsch
and Pusch, 2018). The homologous ClC-K isoforms are, together
with their β-subunit barttin, involved in transepithelial transport
in the nephron, inner ear and salivary glands (Jentsch and Pusch,
2018). The broadly expressed ClC-2 plays diverse physiological
roles by regulating transepithelial transport, extracellular ion
homeostasis and cellular excitability (Stauber et al., 2012; Jentsch
and Pusch, 2018). The physiological importance of these plasma
membrane chloride channels is evident from patients with
mutations of the coding genes and from the phenotypes of
engineeredmousemodels. In case of the ClC-2 knock-outmouse,
the phenotype includes a degeneration of the testes and retina
leading to male infertility and blindness, and leukodystrophy
(Bösl et al., 2001; Nehrke et al., 2002; Blanz et al., 2007;
Cortez et al., 2010). Loss-of-function mutations of ClC-2 have
been described for some leukodystrophy patients (Depienne
et al., 2013; Guo et al., 2019). The two proteins GlialCAM
und MLC1, whose mutations can underlie the leukodystrophy
megalencephalic leukoencephalopathy with subcortical cysts
(MLC) (Leegwater et al., 2001; Lopez-Hernandez et al., 2011),
interact with ClC-2 in glia cells and affect the localization and
biophysical properties of the chloride channel (Jeworutzki et al.,
2012; Hoegg-Beiler et al., 2014). The molecular mechanism
leading to leukodystrophy remains to be elucidated, but changes
in ClC-2 gating (Jeworutzki et al., 2014) do not seem to be
involved (Göppner et al., 2020).
ClC-3 through ClC-7 reside on intracellular organelles,
predominantly of the endosomal-lysosomal pathway, with a
differential distribution between the compartments (Figure 2)
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FIGURE 1 | Structure of CLC exchangers. The structure of human ClC-7 in complex with Ostm1 [Protein Data Bank [PDB]: 7JM7 (Schrecker et al., 2020)] viewed
parallel to the membrane (depicted in gray) is shown as an example for the structure of CLC proteins. The subunits of the CLC homodimer are represented in orange
and magenta. The globular CBS-containing domain of each subunit protrudes into the cytoplasm. Each CLC subunit provides an independent ion transport pathway.
For one subunit, the positions of two key amino acids, the “gating glutamate” (E247 in ClC-7) and the “proton glutamate” (E314 in ClC-7), are indicated. The ClC-7
dimer binds two copies of its β-subunit, Ostm1, presented in green and blue. The heavily glycosylated Ostm1 is thought to shield ClC-7 from acidic proteases in the
lysosomal lumen.
(Suzuki et al., 2006; Wartosch et al., 2009; Stauber et al.,
2012; Stauber and Jentsch, 2013; Jentsch and Pusch, 2018):
ClC-5, which is mainly expressed in the kidney, localizes to
early endosomes where it is involved in endocytic uptake in
the proximal tubule; the ubiquitously expressed ClC-3 and
ClC-4 localize to various endosome populations; ClC-6, which
at protein level is almost exclusively expressed in neurons,
resides on late endosomes; ClC-7 localizes together with its β-
subunit Ostm1 to lysosomes in all cells and additionally to the
ruffled border of bone-resorbing osteoclasts. The physiological
importance of the intracellular CLCs is evident from the broad
spectrum of disorders resulting from their dysfunction in patients
and mouse models (Stauber et al., 2012; Jentsch and Pusch, 2018;
Schwappach, 2020). Neuronal phenotypes, including intellectual
disability, epilepsy, lysosomal storage and neurodegeneration
with ClC-3/-4/-6 and−7, respectively (Stobrawa et al., 2001;
Kasper et al., 2005; Poët et al., 2006; Veeramah et al., 2013; Hu
et al., 2016; Palmer et al., 2018; Nicoli et al., 2019; Polovitskaya
et al., 2020), will be discussed in more detail below. In addition,
mutations in ClC-5 lead to impaired endocytosis in the renal
proximal tubule and kidney stones (Lloyd et al., 1996; Piwon
et al., 2000). Mutations in ClC-7 and the associated Ostm1
underlie osteopetrosis due to its role in osteoclast bone resorption
(Kornak et al., 2001; Chalhoub et al., 2003) and to impaired skin
pigmentation (Nicoli et al., 2019).
ClC-3 though ClC-7 were at first thought to be chloride
channels like their plasma membrane-localized homologs that
mediate the import of negative charge to counterbalance the
electrogenic acidification of the respective organelles (Günther
et al., 1998; Piwon et al., 2000; Kornak et al., 2001). However,
after the discovery that the bacterial EcClC-1 actually mediates
2Cl−/H+ exchange (Accardi and Miller, 2004), this transport
mode has been shown for the five vesicular CLCs as well (Picollo
and Pusch, 2005; Scheel et al., 2005; Graves et al., 2008; Matsuda
et al., 2008; Neagoe et al., 2010; Leisle et al., 2011; Guzman et al.,
2013). It was proposed that instead of merely allowing Cl− influx
to allow for acidification by the V-ATPase, ClC-5 and ClC-3
actively acidified early endosomal compartments by exchanging
the initially high luminal chloride for protons (Smith and Lippiat,
2010; Rohrbough et al., 2018). This transport direction would
be easier to reconcile with the strong outward rectification,
which is observed for all vesicular CLCs upon heterologous
expression at the plasma membrane (Friedrich et al., 1999; Li
et al., 2000; Neagoe et al., 2010; Leisle et al., 2011) because
this would favor Cl− efflux from the lumen through the CLC
when localized intracellular vesicles. However, it is questionable
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FIGURE 2 | Localization of the neuronal intracellular CLCs to distinct, yet
overlapping compartments of the endosomal-lysosomal pathway. ClC-3/ClC-4
localize to various endosomal populations; ClC-6 to late endosomes where it
partially overlaps with ClC-7/Ostm1, the only CLC on lysosomes. ClC-3 is to a
minor extent additionally found on synaptic vesicles. The CLCs exchange 2Cl−
for 1H+ and mediate the accumulation of luminal Cl- in the progressively
acidified organelles.
whether such a mechanism would effectively acidify the lumen
with the typical buffering capacity and it would quickly build
up an inside positive potential that would prevent further Cl−
efflux through the CLC (Stauber et al., 2012). For ClC-3, it
has been shown that low extracytosolic pH partially uncouples
Cl− transport from H+ exchange (Rohrbough et al., 2018). The
authors proposed that at the luminal low pH, ClC-3 would then
function as a Cl− conductance that provided the countercharge
for further acidification by the V-ATPase. However, more
recently, the proton-activated chloride channel PAC has been
shown to mediate Cl− efflux from acidified endosomes (Osei-
Owusu et al., 2021). The increase in endosomal [Cl−] and
reduced pH upon its depletion (Osei-Owusu et al., 2021) are
compatible with the parallel presence of a CLC exchanger that
mediates pH gradient-driven Cl− influx (Jentsch, 2007; Stauber
and Jentsch, 2013). For lysosomes, Cl− accumulation by the ClC-
7 Cl−/H+ exchanger has indeed been shown (Weinert et al.,
2010). The electrogenic 2Cl−/H+ exchange can of course still
support luminal acidification, and this seems to be an important
role for ClC-5 on early endosomes (Novarino et al., 2010).
By contrast, the acidification of lysosomes does not necessarily
depend on parallel Cl− influx as it can be supported by cation
efflux (Steinberg et al., 2010; Weinert et al., 2010). In addition
to the acidification of early endosomes, a pivotal role of the
vesicular CLCs is the pH gradient-dependent secondary active
accumulation of luminal Cl−, as highlighted in engineeredmouse
models in which individual CLC exchangers were mutated to
pure chloride conductors (Novarino et al., 2010; Weinert et al.,
2010, 2020). The importance of lysosomal Cl− is still elusive, but
it may affect further parameters of the vesicular ion homeostasis
including Ca2+ (Stauber and Jentsch, 2013; Chakraborty et al.,
2017; Astaburuaga et al., 2019).
NEUROPATHIES WITH CLC-3 AND CLC-4
ClC-3/ClC-4 Mediate Endosomal Cl–/H+
Exchange in Neurons
Within their branch of CLCs, ClC-3, ClC-4 and ClC-5 share
sequence identity of approximately 80%. Whilst ClC-5 is mainly
expressed in the kidney (Steinmeyer et al., 1995), ClC-3 is widely
expressed and has been detected in virtually all mammalian
tissues, including brain, retina, adrenal gland, heart, liver, kidney,
pancreas, intestines, epididymis and skeletal muscle (Kawasaki
et al., 1994; Borsani et al., 1995; Stobrawa et al., 2001; Maritzen
et al., 2008). Within the brain, ClC-3 is predominantly expressed
in neuronal cells of the hippocampus and Purkinje cells in
the cerebellum (Kawasaki et al., 1994). ClC-3 predominantly
localizes on endosomes (Stobrawa et al., 2001; Hara-Chikuma
et al., 2005; Shibata et al., 2006). Additionally, it is found on
synaptic vesicles (SVs) (Stobrawa et al., 2001; Salazar et al., 2004;
Weinert et al., 2020) and synaptic-like micro vesicles (Salazar
et al., 2004; Maritzen et al., 2008). ClC-4 displays similarly broad
tissue expression as ClC-3, but its relative abundance is lower in
tissues other than brain andmuscle (Van Slegtenhorst et al., 1994;
Mohammad-Panah et al., 2002, 2003; Weinert et al., 2020).
Alternative splice variants of ClC-3 have been reported.
The isoforms (ClC-3A, ClC-3B, and ClC-3C) display
similar transport properties but differential subcellular
localization (Guzman et al., 2015). ClC-3A resides on late
endosomes/lysosomes (Li et al., 2002; Gentzsch et al., 2003),
ClC-3B might localize to the Golgi (Ogura et al., 2002; Gentzsch
et al., 2003), and ClC-3C is targeted to recycling endosomes
via an amino-terminal sorting motif (Guzman et al., 2015).
Upon heterologous expression, ClC-3 through−5 can form
heteromers amongst each other, but not with ClC-6 or ClC-7
(Suzuki et al., 2006). In heterologous expression, ClC-4 is
predominantly retained in the endoplasmic reticulum (ER),
with a minor portion on the plasma membrane (Okkenhaug
et al., 2006; Guzman et al., 2017; Weinert et al., 2020). Co-
expression with distinct ClC-3 splice variants targets ClC-4 to
late endosome/lysosomes (ClC-3A and ClC-3B) or recycling
endosomes (ClC-3C) (Guzman et al., 2017). Also endogenous
ClC-3 and ClC-4 interact in vivo, and ClC-4 requires ClC-3
Frontiers in Cell and Developmental Biology | www.frontiersin.org 4 February 2021 | Volume 9 | Article 639231
Bose et al. CLC Cl−/H+ Exchangers in Neurodegeneration
for ER export and protein stability (Weinert et al., 2020). This,
together with the relative expression levels, suggests that in brain,
ClC-3/ClC-4 function as heterodimers, whereas in other tissues
there may be a more prominent role for ClC-3 homomers.
ClC-4, on the other hand, seems to rely on heteromerization
with ClC-3, which may explain the apparent lack of endosomal
sorting signals in ClC-4 (Stauber and Jentsch, 2010).
There are numerous conflicting studies concerning the
transport properties and cellular functions of ClC-3 (Jentsch
and Pusch, 2018). For example, previously ClC-3 was reported
to function as a plasma membrane chloride channel regulated
by the protein kinase C or the calcium/calmodulin-dependent
protein kinase II (Kawasaki et al., 1994; Huang et al., 2001).
Another function that had been ascribed to ClC-3 was that
of the volume-regulated anion channel (VRAC) (Duan et al.,
1997). However, like many other candidates, ClC-3 was excluded
as VRAC and the typical VRAC currents were unchanged in
the various tested cell types from independent ClC-3 knock-out
mouse models (Stauber, 2015; Jentsch and Pusch, 2018); VRAC
has more recently been shown to be formed by LRRC8 proteins
(Qiu et al., 2014; Voss et al., 2014; König and Stauber, 2019).
Instead, ClC-3 is an outwardly rectifying, vesicular 2Cl−/H+
exchanger like the other intracellular CLCs (Stobrawa et al., 2001;
Matsuda et al., 2008; Guzman et al., 2013, 2015; Rohrbough et al.,
2018). ClC-3 was reported to provide an electrical shunt for the
efficient proton pumping of the electrogenic H+-ATPase into
the lumen, thereby facilitating the acidification of SVs (Stobrawa
et al., 2001; Riazanski et al., 2011; Guzman et al., 2013) and
compartments in the endosomal/lysosomal pathway (Stobrawa
et al., 2001; Hara-Chikuma et al., 2005; Weylandt et al., 2007).
Indeed, endosomal acidification and chloride accumulation were
significantly enhanced in ClC-3A-transfected Chinese hamster
ovary cells and impaired in hepatocytes from ClC-3-deficient
mice (Hara-Chikuma et al., 2005). The acidification of SVs
derived from ClC-3-deficient Clcn3−/− mice was impaired
(Stobrawa et al., 2001; Riazanski et al., 2011). However, the
impaired acidification of SVs can be attributed to a secondary
decrease in the vesicular glutamate transporter VGLUT1, which
itself represents a major Cl− permeation pathway in synaptic
vesicles (Schenck et al., 2009; Preobraschenski et al., 2014;
Eriksen et al., 2016; Martineau et al., 2017). In young Clcn3−/−
mice, before the onset of neurodegeneration (see below) and the
loss of VGLUT1, SV acidification was not impaired (Weinert
et al., 2020). The partial plasma membrane localization of
ClC-4 allowed its electrophysiological characterization as a
strongly voltage-dependent intracellular 2Cl−/H+ exchanger
(Picollo and Pusch, 2005; Scheel et al., 2005). Also for ClC-
4, a role in endosomal acidification was reported, with a more
alkaline endosomal pH and resultant defects in recycling of the
transferrin receptor in fibroblasts derived from ClC-4-deficient
mice (Mohammad-Panah et al., 2003, 2009).
ClC-3/ClC-4 in Neurodegeneration and
Other Neurological Disorders
Three independently generated ClC-3 knock-out mouse models
displayed similar phenotypes of severe postnatal degeneration
of the retina and brain, that led to an almost total loss of the
hippocampus after 3 months (Stobrawa et al., 2001; Dickerson
et al., 2002; Yoshikawa et al., 2002) (Table 1). Neurodegeneration
in these Clcn3−/− mice is not associated with obvious deposits of
lysosomal storage material found in Clcn6−/− or Clcn7−/− mice
(Kasper et al., 2005; Poët et al., 2006) (see below). However, one
Clcn3−/− mouse model displayed deposits of the mitochondrial
ATP synthase subunit c, typically found in the lysosomal storage
disease neuronal ceroid lipofuscinosis (NCL) (Yoshikawa et al.,
2002). The neurodegeneration was accompanied by an activation
of microglia and astrogliosis (Stobrawa et al., 2001; Dickerson
et al., 2002). Despite their severe neurodegeneration, ClC-3
knock-out mice are viable and have a normal life span.
It is tempting to speculate that the severe neurodegeneration
in Clcn3−/− mice is caused by impaired synaptic function.
The frequency and amplitude of miniature excitatory
postsynaptic currents (mEPSCs) in primary neurons from
ClC-3-deficient mice was reported to be reduced, suggesting
that glutamate toxicity due to excessive glutamate release
contributes to the neurodegeneration (Guzman et al., 2014).
However, a recent study found virtually unaltered mEPSCs
(Weinert et al., 2020). Another study reported reduced
miniature inhibitory postsynaptic currents (mIPSCs) in
Clcn3−/− mice (Riazanski et al., 2011), in agreement with
the reduced glutamate uptake in SVs of ClC-3-deficient mice,
but in contrast to mIPSC measurements in a previous study
(Stobrawa et al., 2001). Both the impaired acidification
and the glutamate loading of SVs can be explained by
the concomitant reduction of VGLUT1 in Clcn3−/− mice
(Stobrawa et al., 2001; Schenck et al., 2009; Weinert et al.,
2020), which is a likely consequence–and hence not cause–of
the neurodegeneration.
A recent study described knock-in mice in which the “gating
glutamate” in ClC-3 is replaced by alanine to form the “ClC-
3unc” mutant, in which Cl− transport is uncoupled from H+
countertransport (Weinert et al., 2020). These mice, referred to
as Clcn3unc/unc, presented no obvious phenotype (Table 1). This
is in stark contrast to previous observations from equivalent
mouse models expressing ClC-5unc and ClC-7unc that display
similar phenotypes as the respective knock-out mouse models
(Novarino et al., 2010; Weinert et al., 2010). The explanation
lies in the heteromerization of ClC-3 with ClC-4 (Weinert et al.,
2020). Although mRNA levels of ClC-4 were not significantly
altered in the brain of Clcn3−/− mice, ClC-4 protein levels
were decreased to ∼30%. In contrast, no reduction in ClC-4
levels was observed in Clcn3unc/unc mice. ClC-3unc stabilizes and
promotes the transport of ClC-4 from the ER to endosomal
compartments like wild-type ClC-3. Therefore, ClC-4 may
compensate for a loss of ClC-3 function in Clcn3unc/unc, but
not in Clcn3−/− mice, and the partial loss of ClC-4 may
contribute to the severe neurodegeneration of Clcn3−/− mice
(Weinert et al., 2020). Mice deficient in ClC-4, as well as
Clcn3unc/unc mice displayed no obvious phenotypes (Rickheit
et al., 2010; Hu et al., 2016; Weinert et al., 2020). However, the
combination of these genotypes in Clcn3unc/unc;Clcn4−/− mice
results in an even more severe neurodegeneration than observed
in Clcn3−/− mice (Weinert et al., 2020) (Table 1). Yet, the
milder phenotype of Clcn3unc/unc;Clcn4−/− mice compared to
Clcn3−/−;Clcn4−/− mice suggests that the pure Cl− conductance
of the uncoupled ClC-3unc can also partially substitute for
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No current No proton
transport
No current No proton
transport/no
current
No current No current No proton
transport
Age at death >1 year Normal Normal 5–10 weeks Shortly after
birth
Normal Normal
Weight ↓ Normal Normal ↓ Normal Normal
Neuro-degeneration Yes No No Yes (severe) Yes (very
severe)
Retina degeneration Yes No No Yes
ClC-3 protein levels No Normal Normal Normal No Normal Normal
ClC-4 protein levels ↓ Normal No No No Normal Normal
PH of synaptic
vesicles
Normal in young mice;
↑ in old mice
Normal Normal ↑
Endosomal pH ↑ in hepatocytes;
normal in neurons
↑ Normal






See main text for references.
functions of the wild-type ClC-3 Cl−/H+ exchanger in the
absence of compensating ClC-4 (Weinert et al., 2020). The
absence of neurodegeneration inClcn4−/− mice can be explained
by the remaining, unaltered levels of ClC-3 which may be
sufficient, as ClC-3 can form homodimers and does not require
ClC-4 for its endosomal localization. For the properties of ClC-
3, only subtle consequences of the heteromerization with ClC-4
are expected.
Like in Clcn3−/− mice, the acidification of SVs and
hippocampal miniature postsynaptic currents were unaltered
in Clcn3unc/unc mice before major neuronal loss, suggesting
that the severe neurodegeneration does probably not result
from SV dysfunction (Weinert et al., 2020). Only a minor
fraction of ClC-3 is found on SVs, while also in neurons the
majority is present on endosomes. Endosomal acidification and
concomitant Cl− accumulation was found significantly impaired
in hepatocytes from ClC-3-deficient mice (Hara-Chikuma
et al., 2005). However, pH measurements of transferrin-
positive endosomes in cultured neurons from Clcn3−/− mice
revealed normal acidification (Weinert et al., 2020), resembling
findings with lysosomes from mice lacking ClC-7 or Ostm1
(Kasper et al., 2005; Lange et al., 2006) (see below). Mouse
models expressing ClC-5unc or ClC-7unc suggested an important
role for pH gradient-driven vesicular Cl− accumulation in
early endosomes and lysosomes, respectively (Novarino et al.,
2010; Weinert et al., 2010). So the severe neurodegeneration
observed in Clcn3−/− mice or Clcn3unc/unc/Clcn4−/− mice
may be ascribed to an impairment of endosomal chloride
accumulation rather than to defective endosomal acidification
(Weinert et al., 2020).
So far, no convincing disease-causing mutations have been
identified in the human CLCN3 gene. However, a variety of
inherited and de novo mutations in CLCN4, which in humans is
located X-chromosomal in contrast to the autosomal positioning
of the Clcn4 gene in the laboratory mouse Mus musculus
(Palmer et al., 1995; Rugarli et al., 1995), have recently been
identified in patients with intellectual disability, epilepsy and
behavior disorders, but lacking neurodegeneration (Veeramah
et al., 2013; Hu et al., 2016; Palmer et al., 2018; Zhou et al., 2018).
The identified CLCN4mutations included frameshifts, missense,
intragenic copy number deletion and splice site alterations.
In vitro electrophysiological studies showed that the majority
of the disease-associated missense mutations cause a loss of
function as they diminished or abolished the outwardly rectifying
ClC-4 currents upon heterologous expression. Although no
neurological phenotype and no morphological changes in the
brain were detected in Clcn4−/− mice (Rickheit et al., 2010;
Palmer et al., 2018), the number of dendritic branches and
dendritic length were reduced in primary neurons derived from
Clcn4−/− mice and in knock-down of the Clcn4 gene cultures
neurons (Hur et al., 2013; Hu et al., 2016). This suggests
an involvement of ClC-4 in neuronal differentiation, which
may contribute to the neurological disorders in patients with
CLCN4mutations.
THE LATE ENDOSOMAL CLC-6
ClC-6 and ClC-7, which share ∼45% sequence identity,
constitute the third branch of mammalian CLCs (Brandt and
Jentsch, 1995). Despite the ubiquitous expression of CLCN6
mRNA (Brandt and Jentsch, 1995; Kida et al., 2001), the
protein is almost exclusively found in in neurons (Poët et al.,
2006). Whilst upon heterologous expression in cell culture
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ClC-6 is mainly targeted to recycling endosomes (Ignoul et al.,
2007; Stauber and Jentsch, 2010), endogenous ClC-6 resides
predominantly on Lamp1-positive late endosomes (Poët et al.,
2006), partially overlapping with endosomal ClC-3 and late
endosomal/lysosomal ClC-7 (Stauber et al., 2012; Jentsch and
Pusch, 2018). The partial plasma membrane localization of ClC-
6 with green-fluorescent protein (GFP) fused to its amino-
terminus allowed for its biophysical characterization as a
Cl−/H+ exchanger (Neagoe et al., 2010). ClC-6 shares typical
properties with the other intracellular CLCs, such as the outward
rectification and the uncoupling of Cl− transport from H+
countertransport by mutation of the “gating glutamate.”
ClC-6-deficient Clcn6−/− mice are fertile and display a
normal life pan without any immediately apparent phenotype
(Poët et al., 2006) (Table 2). However, their neurons accumulate
lysosomal storage material, also containing the mitochondrial
ATP synthase subunit c, specifically in the initial axon segments
that become swollen (Poët et al., 2006). Detailed analysis of brains
fromClcn6−/− mice revealed a late-onset—muchmilder than for
ClC-3 or ClC-7 deficiency—neurodegeneration (Pressey et al.,
2010). ClC-6 knock-out mice also exhibited minor cognitive
defects and reduced pain sensitivity, which may arise from the
accumulation of storage material in neurons of the dorsal root
ganglia (Poët et al., 2006). While two out of 75 tested patients
with Kuf ’s disease, which features phenotypes in common with
those found in ClC-6 knock-out mice (Berkovic et al., 1988), were
heterozygous for CLCN6 missense variants, no further evidence
for ClC-6 dysfunction underlying this disease was found (Poët
et al., 2006).
Variations in CLCN6 were identified in patients with epilepsy
(Yamamoto et al., 2015; Wang et al., 2017; Peng et al., 2018;
He et al., 2021). Interestingly, these include a mutation of the
“gating glutamate” at position E200 in the commonly used
CLCN6 transcript variant 1 (He et al., 2021), while the mutation
was referred to as E178A in earlier studies (Wang et al., 2017;
Peng et al., 2018). This amino acid substitution converts ClC-6
into a pure Cl− conductor (Neagoe et al., 2010). Interestingly,
a recent study shows that this ClC-6unc mutant, identified
in a patient with the early infantile epileptic encephalopathy
West syndrome, impairs the autophagic-lysosomal pathway
upon heterologous expression (He et al., 2021). Very recently,
a heterozygous de novo CLCN6 missense mutation was
identified in three independent patients with variable early-
onset neurodegeneration with brainstem lesions and cortical or
cerebral atrophy, respectively (Polovitskaya et al., 2020). The
affected children displayed global developmental delay with
regression and further neurological disorders such as peripheral
sensory neuropathy to varying degrees, but lacked seizures.
The identified mutation, p.Tyr553Cys, affects a tyrosine that
is conserved between the mammalian CLC exchangers. The
electrophysiological characterization of the ClC-6Y553C mutant
revealed that at cytosolic-positive membrane potentials, it
mediated larger currents than wild-type ClC-6, which were not
affected by an extra-cytosolic pH of 5.5 similar to that in late
endosomes. Voltage-dependent activation of the mutant was
slowed down in comparison to wild-type, but the instantaneous
currents were already of the amplitude of maximal wild-type
currents. So this mutation resulted in a gain of function
(Polovitskaya et al., 2020). Upon heterologous expression in
cultured cells it colocalized with the marker protein Lamp1
to drastically enlarged late endosomal structures (Polovitskaya
et al., 2020), resembling those observed with gain-of-function
TABLE 2 | Mouse models with Clcn6 or Clcn7 mutations.
Clcn6−/− Clcn7−/− Clcn7unc/unc Clcn7td/td Clcn7G213R/G213R Clcn7F316L/F316L Clcn7+/Y713A
Transporter
properties

















Age at death Normal 4-6 weeks Up to 5 weeks Up to 6
weeks
Up to 30 days Up to 30 days 18 weeks
(heterozygous)
Fur color Normal Gray Normal Normal Albinism
Bone mineralization ↑ ↑ ↑ ↑ ↑ Normal
Storage material Yes Yes Yes Yes Yes Yes
Neuro-degeneration No Yes Yes Yes Yes Yes
Retina degeneration ↑ ↑ No
Autophagic
accumulation
↑ ↑ No ↑
Lysosomal pH Normal Normal Normal Normal ↑ ↓










See main text for references.
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ClC-7 mutant (Nicoli et al., 2019) (see below). The lumen of
these vacuoles was poorly acidified (Polovitskaya et al., 2020),
which may cause alterations of membrane fusion and fission
with or from these structures. The consequent impairment
of the endosomal-lysosomal pathway is likely to underlie the
neuropathy of the patients.
The two disease-causing mutations have differential effects
on the ion transport properties of ClC-6. However, the fact
that loss of ClC-6 in Clcn6−/− mice leads to only mild
phenotypes (Poët et al., 2006), suggests that the heterozygous
ClC-6E200A, just like ClC-6Y553C (Polovitskaya et al., 2020),
presents a gain-of-function mutation. The uncoupling of
chloride transport from proton countertransport by the
E200A mutation may be considered a loss of function.
Indeed, mouse models expressing the equivalent mutation
in ClC-5 or ClC-7 display similar disorders as the respective
knock-out models (Novarino et al., 2010; Weinert et al.,
2010). However, these uncoupling mutations additionally
abolish the outward rectification of the CLC and hence would
increase currents at luminal positive potentials, which may
well be of patho-physiological relevance. Nonetheless, the two
ClC-6 mutations also affect the morphology of endosomal
compartments differentially –with only mildly or drastically
enlarged compartments for ClC-6E200A and ClC-6Y553C,
respectively (Polovitskaya et al., 2020)– and eventually lead






The ubiquitously expressed ClC-7 is the only member of the CLC
protein family that primarily localizes to lysosomes (Brandt and
Jentsch, 1995; Kornak et al., 2001). In bone-resorbing osteoclasts,
it additionally resides in the ruffled border, a specialized
membrane domain built up by the fusion of lysosomes with the
plasma membrane (Teitelbaum, 2000; Kornak et al., 2001). It
forms a stable complex with the single-pass type I membrane
protein Ostm1 (for osteopetrosis-associated membrane protein
1) (Lange et al., 2006; Schrecker et al., 2020; Zhang et al., 2020)
(Figure 1). This interaction is required for stability for protein
stability of ClC-7, likely due to the heavily N-glycosylated Ostm1,
of which two subunits bind to the ClC-7 dimer, shielding the
unglycosylated ClC-7 from lysosomal proteases (Lange et al.,
2006; Schrecker et al., 2020; Zhang et al., 2020), and for ion
transport by the ClC-7/Ostm1 complex (Leisle et al., 2011). On
the other hand, Ostm1 is reliant on ClC-7 for exit from the ER
and lysosomal targeting (Lange et al., 2006; Leisle et al., 2011).
Hence, a drastic reduction in protein levels can be observed for
Ostm1 in tissues of ClC-7-deficient Clcn7−/− mice and for ClC-
7 in spontaneous Ostm1-deficient grey-lethal mouse line (Lange
et al., 2006). Ostm1 is a 70 kDa protein which is proteolytically
processed upon arrival in lysosomes (Lange et al., 2006). Recently
solved cryo-EM structures of ClC-7/Ostm1 revealed that the
luminal domain of Ostm1 has a tightly packed core of helical
bundles linked with several disulfide bonds (Schrecker et al.,
2020; Zhang et al., 2020).
In osteoclasts, expression of ClC-7 and Ostm1 are coregulated
by the transcription factor microphthalmia (Meadows et al.,
2007). In addition, ClC-7 expression has been shown to be
upregulated, like that of many lysosomal proteins, by the
transcription factor TFEB (Sardiello et al., 2009). The subcellular
localization of ClC-7/Ostm1 on late endosomes/lysosomes has
been shown by various means for all tested tissues and cell
types, including neurons, fibroblasts, renal proximal tubule
cells, liver, macrophages, activated microglia and HeLa cells
(Kornak et al., 2001; Kasper et al., 2005; Graves et al., 2008;
Wartosch et al., 2009; Steinberg et al., 2010; Majumdar et al.,
2011; Hennings et al., 2012). Lysosomal localization increases
reportedly during microglia activation (Majumdar et al., 2011).
Recently, an influence of protein kinase A (PKA) signaling on
lysosomal delivery of ClC-7/Ostm1 and an impairment thereof
in presenelin-1 knock-out has been proposed (Lee et al., 2020).
In neurons, the ClC-7 may partially overlap with ClC-6 in their
localization to late endosomes, but ClC-7 is exclusively found
on lysosomes to which ClC-6 is only shifted in brain of ClC-7-
deficient mice (Poët et al., 2006).
Like for ClC-6, the exclusive intracellular localization of ClC-7
hampered a biophysical characterization of the protein for several
years. The presence of a conserved “proton glutamate” (E312 or
E314 in mouse and human ClC-7, respectively) pointed to the
activity of ClC-7 as a Cl−/H+ antiporter. This was confirmed
by flux measurements on isolated lysosomes (Graves et al.,
2008) and with lysosomes in living cells, including ClC-7 knock-
out cells as control (Weinert et al., 2010). Subsequently, the
identification of endosomal sorting motifs in the amino-terminal
domain of ClC-7 enabled partial cell surface localization of ClC-
7/Ostm1 (Stauber and Jentsch, 2010). The plasma membrane-
targeted ClC-7 mutant depleted of the sorting motifs, referred
to as ClC-7PM, mediates strongly outward-rectifying voltage-
activated currents by exchanging 2 Cl− for 1 H+ (Leisle et al.,
2011). Both Cl− and H+ transport could also be visualized in an
optical activity assay for ClC-7/Ostm1 (Zanardi et al., 2013). The
electrophysiological analysis revealed that ClC-7/Ostm1 shares
many properties with the other intracellular CLCs, including the
uncoupling of Cl− transport from proton countertransport and
the drastic reduction in transport upon mutation of the “gating”
and “proton” glutamates, respectively (Leisle et al., 2011). ClC-
7PM required co-expression of Ostm1 for ion transport activity
(Leisle et al., 2011), which may be due to minor effects of Ostm1
on the ion translocation pathway in the ClC-7 subunit (Schrecker
et al., 2020). A striking difference to the currents mediated by the
endosomal CLCs was the slow activation and relaxation kinetics
of ClC-7/Ostm1 (Leisle et al., 2011). This slow “gating” involves
the common gating of the subunits (Ludwig et al., 2013) and
depends on the interaction of the ClC-7 transmembrane domain
interface with the amino-terminus and the CBS domains of the
C-terminal region (Leisle et al., 2011; Schrecker et al., 2020;
Zhang et al., 2020).
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Neurodegeneration in Mouse Models With
Dysfunction of ClC-7/Ostm1
The physiological importance of ClC-7/Ostm1 was first revealed
by the analysis of engineered Clcn7−/− mice (Kornak et al.,
2001) and the grey-lethal mouse line, which was found to
harbor a mutation leading to Ostm1 deficiency (Chalhoub
et al., 2003). Homozygous mice of both lines develop a severe
osteopetrosis, i.e., hypermineralization of bones and obliteration
of bone marrow cavities, accompanied by secondary effects
such as a lack of tooth eruption. The osteopetrosis is owed to
an impairment in the build-up and in the acidification of the
osteoclast ruffled border (Kornak et al., 2001; Rajapurohitam
et al., 2001; Stauber et al., 2012; Jentsch and Pusch, 2018). The
mice display a shortened life span of only few weeks. In an
agouti background, when wild-type mice have brown fur, ClC-
7- and Ostm1-deficient mice have a gray coat color, suggesting a
role for ClC-7/Ostm1 in hair pigmentation (Kornak et al., 2001;
Chalhoub et al., 2003).
Besides the immediately obvious osteopetrotic phenotype,
Clcn7−/− and grey-lethal mice develop a progressive
neurodegeneration in the brain and retina (Kasper et al.,
2005; Lange et al., 2006; Pressey et al., 2010). Neurons of various
brain regions accumulated electron-dense deposits in lysosomes
scattered throughout the cell bodies (Kasper et al., 2005). With
the autofluorescence of the lysosomal storage material and the
accumulation of the subunit c of themitochondrial ATP synthase,
the phenotype resembled a neuronal ceroid lipofuscinosis (NCL).
Neuronal cell loss, prominent in the hippocampal CA3 region,
in the thalamocortical system and of Purkinje cells in the
cerebellum, was accompanied by inflammatory responses such
as microglia activation and astrogliosis, another hallmark of
NCL and other neurodegenerative pathologies, in Clcn7−/−
mice (Kasper et al., 2005; Pressey et al., 2010). The generation
of tissue-specific ClC-7 knock-out mice enabled the analysis of
neurodegeneration in mice with a normal life span (Wartosch
et al., 2009). Brains of adult mice with a forebrain-specific ClC-7
knock-out (Clcn7lox/lox;EMX1-cre), displayed conspicuous loss
of hippocampal and cortical neurons. Starting in the CA3 region
of hippocampus neuronal loss progressed into the dentate
gyrus and by the age of 1.5 years no hippocampal structures in
Clcn7lox/lox;EMX1cre mice could be detected (Wartosch et al.,
2009). In vivo protein degradation experiments using kidney-
specific ClC-7 knock-out mice (Clcn7lox/lox;ApoE-cre) revealed
slowed lysosomal degradation of endocytosed protein (Wartosch
et al., 2009). Consistent with an impairment of lysosomal
function, grey-lethalmice accumulated sphingolipids in the brain
(Prinetti et al., 2009) and an increase in the autophagic marker
LC3-II was observed in brain and kidney of Clcn7−/− and in
grey-lethal mice (Wartosch et al., 2009; Heraud et al., 2014), but
it is not clear whether this is due to reduced autophagosome
clearance or an induction of autophagy (Wartosch and Stauber,
2010).
Lysosomes in neurons and other cells from ClC-7- or Ostm1-
deficient mice were found to be normally acidified (Kasper et al.,
2005; Lange et al., 2006; Steinberg et al., 2010), contradicting
the previous assumption that ClC-7 mediated the required
counterion transport for the lysosomal acidification. Instead,
the counterion conductance can be provided by cation efflux
from lysosomes (Steinberg et al., 2010; Weinert et al., 2010).
Clcn7unc/unc mice, in which ClC-7 functions as a pure Cl−
conductor due to the E245A mutation of its “gating glutamate”
did not display a fur color phenotype and they presented an
osteopetrosis that was milder than in Clcn7−/− mice (Weinert
et al., 2010). However, they developed the same lysosomal
storage disease and neurodegeneration as ClC-7 knock-out mice
(Table 2). As in in Clcn7−/− cells, lysosomes were acidified to
the normally low pH. As predictable from model calculations
(Weinert et al., 2010; Ishida et al., 2013; Astaburuaga et al.,
2019), the lysosomal Cl− concentration was reduced in both
Clcn7−/− andClcn7unc/unc mice compared to wild-type (Weinert
et al., 2010). Similar results, reduced [Cl−] but normally acidic
pH, were obtained with nematode models with reduced ClC-7
or Ostm1 orthologs (Chakraborty et al., 2017). Together with
the equivalent ClC-3unc and ClC-5unc knock-in mouse models,
this suggests an important, acidification-independent role for
Cl− accumulation in the endo-lysosomal pathway, while in
early endosomes Cl− additionally supports luminal acidification
(Novarino et al., 2010; Weinert et al., 2010, 2020; Scott and
Gruenberg, 2011; Stauber and Jentsch, 2013; Schwappach, 2020).
Another knock-in mouse model expressed ClC-7 with a
E312A mutation of the “proton glutamate,” dubbed ClC-7td
because of the supposed transport deficiency of the mutant
(Weinert et al., 2014) (Table 2). Like Clcn7unc/unc mice, these
Clcn7td/td mice lacked a coat color phenotype. However, in
contrast to Clcn7unc/unc mice, the osteopetrosis of Clcn7td/td
mice was as pronounced as in Clcn7−/− mice, but intriguingly
their neuropathy with lysosomal storage and neurodegeneration
was less severe and no accumulation of autophagic material
was detected (Weinert et al., 2014). An explanation for the
differential effects in the mouse models may be that the Cl−
conductance of ClC-7unc could partially compensate for ClC-
7 loss in its osteoclast function in bone resorption, while it
is deleterious for neuronal lysosomes. On the other hand,
the presence of the ClC-7td protein–and with that of Ostm1
which is normally transported to lysosomes in Clcn7td/td mice
(Weinert et al., 2014)–can sustain lysosomal function in neurons,
possibly by protein-protein interactions as proposed for Ostm1
(Pandruvada et al., 2016). An alternative explanation for the
milder neuropathy of Clcn7td/td mice compared to Clcn7−/−
mice was recently provided by the unexpected finding that
the mutation of the “proton glutamate” to alanine does not
completely abolish currents by ClC-7td (Pusch and Zifarelli,
2021). With its residual ion transport activity, ClC-7td may
partially exert its function in the neuronal endo-lysosomal
pathway. Nonetheless, while lysosomes of Clcn7td/td mice were
normally acidified, the lysosomal Cl− concentration was reduced
(Weinert et al., 2014).
Patient CLCN7 Mutations Causing
Neuropathies
Mutations inCLCN7 andOSTM1 also underlie severe, autosomal
recessive osteopetrosis (ARO) in humans (Kornak et al., 2001;
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Chalhoub et al., 2003). In addition, intermediate autosomal
osteopetrosis (IAO) and the milder, autosomal dominant
osteopetrosis type 2 (ADO2, or Albers-Schönberg disease) are
caused by CLCN7 mutations (Cleiren et al., 2001; Frattini et al.,
2003; Sobacchi et al., 2013). The most severe forms of CLCN7-
related ARO in about 50% of the cases, as well as OSTM1-related
ARO, are also neuropathic with primary neurodegeneration
manifesting in developmental delay, hypotonia, retinal atrophy
and seizures (Steward, 2003; Pangrazio et al., 2006; Sobacchi
et al., 2013), which is critical for therapy (Teti and Econs, 2017).
Dominant CLCN7 mutations, which may lead to subcellular
mislocalization of the ClC-7/Ostm1 complex or the impingement
of the dysfunctional subunit on the ion transport properties of
the unaffected subunit (Schulz et al., 2010; Ludwig et al., 2013),
do not lead to neuropathy in mild ADO2. A mouse model
recapitulating the most common ClC-7 mutation in ADO2,
G215R (G213R in mouse), which was reported to impinge
on subcellular trafficking (Schulz et al., 2010), developed a
late-onset osteopetrosis as expected for heterozygous animals
while homozygous mice displayed a phenotype similar to
that of Clcn7−/− mice with death after only a few weeks
and neurodegeneration (Alam et al., 2014) (Table 2). Similar
findings were made with another ADO2 mouse model with the
F318L (F316L in mouse) mutation (Caetano-Lopes et al., 2017),
which strongly diminishes currents mediated by ClC-7PM/Ostm1
(Leisle et al., 2011). However, heterozygous Clcn7+/G213R ADO2
mice also presented fibrosis in non-skeletal tissues such as
lung and muscle; their brains exhibited perivascular fibrosis, β-
amyloid accumulation and astrogliosis, and the animals showed
behavioral abnormalities (Maurizi et al., 2019).
During the first electrophysiological analysis of osteopetrosis-
causing ClC-7 missense mutations, it was surprisingly found
that, besides loss-of-function mutations due to impaired ER exit
or reduced ion transport, several pathogenic ClC-7 mutations
accelerated the voltage-dependent activation of ClC-7PM/Ostm1
(Leisle et al., 2011). Most of the amino acids changed by
these mutations are involved in the interaction between the
transmembrane domain and the cytoplasmic CBS domains of
ClC-7, which highlights the role of the domain interface in
the common gating that is responsible for the slow activation
kinetics (Leisle et al., 2011; Ludwig et al., 2013; Schrecker et al.,
2020; Zhang et al., 2020). Such apparent gain-of-function by
fast exchanger activation was subsequently shown for further
mutants (Barvencik et al., 2014; Sartelet et al., 2014; Di Zanni
et al., 2020). There seems to be no strict correlation between the
effect a given mutation exerts on the current properties–whether
it diminishes currents or accelerates the voltage-dependent
activation–and the neuropathy of osteopetrosis. Instead, it was
recently proposed that the mere presence of ClC-7/Ostm1 may
determine the severity of the disease (Di Zanni et al., 2020), but
the genotype-phenotype correlation is far from clarified.
Recently, a heterozygous de novo mutation of ClC-7 was
identified in two children with hypopigmentation and delayed
development (Nicoli et al., 2019). The patients exhibited
organomegaly and their brains displayed delayed myelination, a
thin posterior corpus callosum, hyperintensity of the subthalamic
nuclei, and cerebellar atrophy in MRI. Remarkably, they had no
signs of osteopetrosis. Huge intracellular vacuoles and storage
material was found in various tested tissues. The phenotype
of knock-in mice heterozygous for the identified Y715C
(Y713C in mouse) mutation recapitulated the disease (Nicoli
et al., 2019) (Table 2). Electrophysiological characterization
of the mutant revealed a tremendous increase in current
amplitude. Heterologous expression of ClC-7Y715C led to a
drastic enlargement of late endosomal/lysosomal compartments
(Nicoli et al., 2019), similar to those with the gain-of-
function ClC-6Y553C mutant (Polovitskaya et al., 2020). In
the case of ClC-7Y715C, the enlarged compartments were
reported not to be acidified in contrast to surrounding
smaller, hyperacidified lysosomes, which was attributed to the
hyperactivity of the ClC-7 mutant (Nicoli et al., 2019). The
mechanism of the endosomal/lysosomal enlargement remains
elusive. This mutant corroborates the notion that osteopetrosis
and neuropathy with ClC-7 mutations may develop with
independent pathomechanisms as ClC-7 may exert cell type-
specific functions.
CONCLUSIONS
Loss-of-function and in some cases also gain-of-function of the
intracellular CLCs, ClC-3/ClC-4, ClC-6 and ClC-7/Ostm1, lead
to neuropathies, often neurodegeneration. They all function as
Cl−/H+ exchangers on distinct, but overlapping organelles of the
endosomal-lysosomal pathway (Stauber et al., 2012; Jentsch and
Pusch, 2018). Trafficking and function of these compartments
is detrimental for cellular physiology and dysfunction of
the degradative pathway, lysosomal clearance by exocytosis
or autophagic delivery to this pathway are associated with
neurodegenerative disorders (Hara et al., 2006; Komatsu et al.,
2006; LaPlante et al., 2006; Nixon, 2013; Wang et al., 2013;
Menzies et al., 2017; Ballabio and Bonifacino, 2020; Mallucci
et al., 2020).
In some cases, it has been proposed that the CLC serves as a
structural protein that functions to recruit other proteins such as
components of the transport machinery by direct protein-protein
interaction. Amongst others, the existence of different missense
mutations which unlikely all prevent the same interactions
argues against this. Although a role a role for protein-protein
interactions of intracellular CLCs in vesicular trafficking cannot
be excluded, the most straight-forward explanation for the
importance of CLCs is their role in the regulation of the vesicular
ion homeostasis. In this respect, the pronounced outward
rectification of the vesicular CLCs remains enigmatic, because
it would strongly favor Cl− export from endosomes/lysosomes.
At membrane voltages in the range of those measured for
endosomal/lysosomal compartments, which can be up to inside-
positive 100mV (Koivusalo et al., 2011; Saminathan et al.,
2021), the CLC exchangers are virtually inactive in heterologous
expression systems (Friedrich et al., 1999; Li et al., 2000; Neagoe
et al., 2010; Leisle et al., 2011). Nonetheless, the effects of CLC
depletion or various mutations -both loss and gain of function-
demonstrate Cl− accumulation by CLCs and the necessity of
their ion transport. Mutation of the “gating glutamate” does not
Frontiers in Cell and Developmental Biology | www.frontiersin.org 10 February 2021 | Volume 9 | Article 639231
Bose et al. CLC Cl−/H+ Exchangers in Neurodegeneration
only convert the exchanger into a pure Cl− conductor, but also
abolishes its voltage dependence. Therefore, such amutationmay
indeed represent a gain of function in respect to Cl− transport.
Interestingly, while the uncoupling mutation of ClC-5 or ClC-
7 leads to effects that are similar to the respective knock-out in
mouse models, the heterozygous mutant of ClC-6 results in a
much more severe disorder in patients than in the murine gene
knock-out model (Poët et al., 2006; He et al., 2021).
The luminal pH is of undisputed importance for endosomes
and lysosomes and impaired acidification is linked to
neurodegeneration (Mellman et al., 1986; Mindell, 2012;
Song et al., 2020). However, while the early endosomal ClC-5
critically supports acidification by providing the counterion
(Günther et al., 1998; Piwon et al., 2000), this does not seem to
be the case for ClC-3/-4, ClC-6 or ClC-7 on later endosomes
and lysosomes (Kasper et al., 2005; Poët et al., 2006; Weinert
et al., 2020) where the larger cation conductance can support
acidification (Van Dyke, 1993; Steinberg et al., 2010). Instead,
analyses of various mouse models have shown that the secondary
active, pH-gradient driven accumulation of Cl− by their Cl−/H+
exchange mechanism is pivotal –also for ClC-5, in addition to
the acidification- (Novarino et al., 2010; Weinert et al., 2010,
2020). Along the endosomal-lysosomal pathway, the luminal Cl−
concentration rises to > 100mM in the lysosome (Saha et al.,
2015). Reduced lysosomal Cl− concentrations, but a normally
low pH, have been found in nematode models of various
neurodegenerative lysosomal storage diseases including Gaucher
and Nieman-Pick A and B (Chakraborty et al., 2017). The Cl−
concentration has been shown to influence the enzymatic activity
of the lysosomal protease cathepsin C (Cigić and Pain, 1999), but
FIGURE 3 | Schematic representation of various (partially putative) components of the interconnected system of ensosomal/lysosomal ion homeostasis. CLC
exchanger activity (here exemplary of ClC-7) directly affects the luminal pH and Cl− concentration. These will affect the transmembrane voltage 1Ψ and
concentrations of further ion species and hence osmolarity. The cartoon was created using Servier Medical Art templates (https://smart.servier.com) licensed under a
Creative Commons License (https://creativecommons.org/licenses/by/3.0/). The figure was taken from Astaburuaga et al. (2019).
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the general mechanism by which luminal Cl− affects vesicular
function is elusive (Stauber and Jentsch, 2013).
The presence of a Cl−/H+ exchanger does not only –
if at all– affect the luminal Cl− concentration and pH, but
ion homeostasis in general, including the transmembrane
voltage and concentrations of other ion species (Ishida et al.,
2013; Stauber and Jentsch, 2013; Astaburuaga et al., 2019)
(Figure 3). One particularly important ion species that may
be affected is Ca2+ (Chakraborty et al., 2017; Astaburuaga
et al., 2019), as it is crucially involved in signaling and
trafficking in the endosomal-lysosomal pathway (Luzio et al.,
2007; Morgan et al., 2011; Ureshino et al., 2019; Lakpa et al.,
2020). In addition, the exchange activity of CLCs has osmotic
effects on the respective organelles. The enlargement of late
endosomal/lysosomal compartments upon overexpression of
ClC-3 (Li et al., 2002) or with gain-of-function mutants of ClC-
6 or ClC-7 (Nicoli et al., 2019; Polovitskaya et al., 2020), may be
partially due to osmotic swelling. Furthermore, osmotic volume
changes promote membrane trafficking events (Freeman and
Grinstein, 2018; Freeman et al., 2020; Saric and Freeman, 2020)
and the number of known osmo-sensitive cation channels of
endosomes and lysosomes is growing (Chen et al., 2020a,b).
Recently, the LRRC8-formed volume-regulated anion channel
(VRAC) has been reported to localize to lysosomes where it
contributed to cellular osmoreglation (Li et al., 2020). This
plasma membrane channel, which is involved in multiple
physiological processes, does not only mediate cell volume
regulatory ion transport (Chen et al., 2019). By releasing
glutamate from swollen cells under ischemic conditions, it
contributes to excitotoxicity and neuronal cell death after stroke
(Mongin, 2016; Yang et al., 2019).
In summary, dysfunction of the intracellular CLC Cl−/H+
exchangers impinges on the trafficking, function and
possibly signaling of endosomal and lysosomal organelles
and interconnected pathways such as autophagy, which in
turn leads to cell death of vulnerable neurons. Future work
is required to uncover in detail the molecular mechanism
by which these CLCs contribute to the functioning of the
endosomal-lysosomal pathway.
AUTHOR CONTRIBUTIONS
SB, HH, and TS wrote the manuscript. All authors contributed to
the article and approved the submitted version.
FUNDING
This work was supported by grants from the German Federal
Ministry of Education and Research (BMBF, Grant No. 031A314)
and the German Research Foundation (DFG, FOR 2625) to TS,
and by a fellowship from the China Scholarship Council to HH.
ACKNOWLEDGMENTS
We acknowledge support by the Open Access Publication
Initiative of Freie Universität Berlin.
REFERENCES
Accardi, A., and Miller, C. (2004). Secondary active transport mediated by
a prokaryotic homologue of ClC Cl− channels. Nature 427, 803–807.
doi: 10.1038/nature02314
Alam, I., Gray, A. K., Chu, K., Ichikawa, S., Mohammad, K. S., Capannolo, M.,
et al. (2014). Generation of the first autosomal dominant osteopetrosis type II
(ADO2) disease models. Bone 59, 66–75. doi: 10.1016/j.bone.2013.10.021
Astaburuaga, R., Quintanar Haro, O. D., Stauber, T., and Relógio, A. (2019). A
mathematical model of lysosomal ion homeostasis points to differential effects
of Cl(-) transport in Ca(2+) dynamics. Cells 8:1263. doi: 10.3390/cells8101263
Ballabio, A., and Bonifacino, J. S. (2020). Lysosomes as dynamic
regulators of cell and organismal homeostasis. Nat. Rev. 21, 101–118.
doi: 10.1038/s41580-019-0185-4
Barvencik, F., Kurth, I., Koehne, T., Stauber, T., Zustin, J., Tsiakas, K., et al.
(2014). CLCN7 and TCIRG1 mutations differentially affect bone matrix
mineralization in osteopetrotic individuals. J. Bone Miner. Res. 29, 982–991.
doi: 10.1002/jbmr.2100
Berkovic, S. F., Carpenter, S., Andermann, F., Andermann, E., and Wolfe,
L. S. (1988). Kufs’ disease: a critical reappraisal. Brain 111, 27–62.
doi: 10.1093/brain/111.1.27
Blanz, J., Schweizer, M., Auberson, M., Maier, H., Muenscher, A., Hübner, C. A.,
et al. (2007). Leukoencephalopathy upon disruption of the chloride channel
ClC-2. J. Neurosci. 27, 6581–6589. doi: 10.1523/JNEUROSCI.0338-07.2007
Boland, B., Yu, W. H., Corti, O., Mollereau, B., Henriques, A., Bezard,
E., et al. (2018). Promoting the clearance of neurotoxic proteins in
neurodegenerative disorders of ageing. Nat. Rev. Drug Discovery 17, 660–688.
doi: 10.1038/nrd.2018.109
Borsani, G., Rugarli, E. I., Taglialatela, M., Wong, C., and Ballabio, A. (1995).
Characterization of a human and murine gene (CLCN3) sharing similarities
to voltage-gated chloride channels and to a yeast integral membrane protein.
Genomics 27, 131–141. doi: 10.1006/geno.1995.1015
Bösl, M. R., Stein, V., Hübner, C., Zdebik, A. A., Jordt, S. E., Mukhophadhyay, A.
K., et al. (2001). Male germ cells and photoreceptors, both depending on close
cell-cell interactions, degenerate upon ClC-2 Cl−-channel disruption. EMBO J.
20, 1289–1299. doi: 10.1093/emboj/20.6.1289
Brandt, S., and Jentsch, T. J. (1995). ClC-6 and ClC-7 are two novel broadly
expressed members of the CLC chloride channel family. FEBS Lett. 377, 15–20.
doi: 10.1016/0014-5793(95)01298-2
Caetano-Lopes, J., Lessard, S. G., Hann, S., Espinoza, K., Kang, K. S., Lim, K. E.,
et al. (2017). Clcn7F318L/+ as a new mouse model of Albers-Schönberg disease.
Bone 105, 253–261. doi: 10.1016/j.bone.2017.09.007
Chakraborty, K., Leung, K., and Krishnan, Y. (2017). High lumenal
chloride in the lysosome is critical for lysosome function. Elife 6:e28862.
doi: 10.7554/eLife.28862.026
Chalhoub, N., Benachenhou, N., Rajapurohitam, V., Pata, M., Ferron, M.,
Frattini, A., et al. (2003). Grey-lethal mutation induces severe malignant
autosomal recessive osteopetrosis in mouse and human. Nat. Med. 9, 399–406.
doi: 10.1038/nm842
Chen, C. C., Krogsaeter, E., Butz, E. S., Li, Y., Puertollano, R., Wahl-Schott,
C., et al. (2020a). TRPML2 is an osmo/mechanosensitive cation channel
in endolysosomal organelles. Sci. Adv. 6:eabb5064. doi: 10.1126/sciadv.
abb5064
Chen, L., König, B., Liu, T., Pervaiz, S., Razzaque, Y. S., and Stauber,
T. (2019). More than just a pressure relief valve: physiological roles of
volume-regulated LRRC8 anion channels. Biol. Chem. 400, 1481–1496.
doi: 10.1515/hsz-2019-0189
Chen, C. C., Krogsaeter, E., and Grimm, C. (2020b). Two-pore and
TRP cation channels in endolysosomal osmo-/mechanosensation and
volume regulation. Biochim. Biophys. Acta Mol. Cell Res. 1868:118921.
doi: 10.1016/j.bbamcr.2020.118921
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